Endocrine and Metabolic Effects of Glucagon Used as a Premedication in Upper Gastrointestinal Endoscopy of Diabetic Patients. Compared with Scopolamine Butylbromide.:Compared with Scopolamine Butylbromide
スポンサーリンク
概要
- 論文の詳細を見る
Endocrine and metabolic effects of glucagon as a premedication in endoscopic examinations of the upper gastrointestinal tract of diabetic patients were investigated. We measured the levels of blood glucose, immunoreactive insulin, growth hormone and adrenocorticotropic hormone after intramuscular injection of glucagon in the diabetic patients (n=7) and in non-diabetic subjects (n=10) before upper gastrointestinal endoscopy. Scopolamine butylbromide was used in a control study to evaluate and compare the effects of glucagon.<BR>The maximal increase in the levels of blood glucose after intramuscular injection was about 96 mg/d<I>l</I> from basal in the diabetic patients and 55mg/d<I>l</I> from basal in the non-diabetic subjects, and the increase after 120 minutes was 39.0mg/dl in diabetic patients and -2.1mg/d<I>l</I> in the nondiabetic subjects. However, there was no change in blood glucose levels after intramuscular injection of scopolamine butylbromide in both diabetic patients and non-diabetic subjects. Serum levels of immunoreactive insulin changed in parallel with the levels of blood glucose. There was a significant difference in the serum levels of growth hormone between glucagon and scopolamine butylbromide injections. There was no statistical difference in serum levels of adrenocorticotropic hormone between glucagon and scopolamine butylbromide injections.<BR>In one of ten non-diabetic subjects injected with glucagon, mild asymptomatic reactive hypoglycemia (41mg/d<I>l</I>) was observed but no therapy was required. No other untoward effects of glucagon were noted in either diabetic patients or non-diabetic subjects.<BR>Thus, glucagon can be safely used in diabetic patients as a premedicative drug for an endoscopic examination, especially in cases in which anticholinergic drugs are contraindicated.
- 一般社団法人 日本糖尿病学会の論文
一般社団法人 日本糖尿病学会 | 論文
- Hyperlipidemia and Analysis of the Use of Lipid-lowering Drugs in Non-insulin-dependent Diabetes Mellitus.
- Thyrotoxic Crisis in a Patient with Mitochondrial Diabetes Mellitus.
- Rapidly Progressive Nephropathy in a Young Patient with Mitochondrial Gene Mutation.
- An Autopsy Case of Ketoacidosis in Insulin Dependent Diabetes Mellitus Patient Complicated with Adult Respiratory Distress Syndrome, DIC and Leukopenia.
- Studies on Alcoholic Beverages in Relation to Body Weight for Mild Diabetics